In this issue of , Kiel et al identify novel and high-frequency gain-of-function mutations involving genes of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway in T-cell prolymphocytic leukemia (T-PLL), paving the way for new targeted therapies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148755 | PMC |
http://dx.doi.org/10.1182/blood-2014-06-576942 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!